This Form 3 is a standard administrative filing with no trading signal. Monitor for subsequent Form 4 filings to track any insider buying or selling activity by Berger.
Price Chart
Executive Summary
Franklin M. Berger filed an initial Statement of Beneficial Ownership (Form 3) with Retension Pharmaceuticals, Inc., disclosing 12,517 shares of common stock and options to purchase 9,662 shares at $2.43, along with an undisclosed number of Series B Convertible Preferred Stock that converts to common stock. This is a routine insider filing required upon becoming a reporting person and contains no material financial or operational news for the company.
Key Facts
- Franklin M. Berger filed Form 3 as a new reporting person at Retension Pharmaceuticals, Inc.
- Berger directly owns 12,517 shares of common stock.
- Berger holds options to purchase 9,662 shares of common stock at $2.30 per share, expiring April 30, 2036.
- Berger also holds Series B Convertible Preferred Stock (number of shares not disclosed), convertible into common stock and automatically converting at IPO closing.
- The filing includes a Power of Attorney appointing Alex Schwartz to handle Section 16 filings.
- No transactions or changes in ownership are reported — this is an initial statement only.
Financial Impact
No financial impact — routine initial beneficial ownership filing with no transaction or material corporate event.
Risk Factors
- No material risks identified from this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001213900-26-108133 |
| Document: 0001213900-26-108133-index-headers.html | 0001213900-26-108133 |
| Document: 0001213900-26-108133-index.html | 0001213900-26-108133 |
| Document: 0001213900-26-108133.txt | 0001213900-26-108133 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 8-K | $15.25 | awaiting T+5 | — | $15.25 (0.00%) |
Oct 16, 2026 10d ago | SC 13G | $16.33 $14.65 | ▼ −10.29% | ▼ −10.14% | $15.25 (−6.61%) |
Oct 16, 2026 10d ago | SC 13G | $14.07 $15.25 | ▲ +8.39% | ▲ +8.82% | $15.25 (+8.39%) |
Oct 15, 2026 11d ago | SC 13G | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $15.25 (+24.90%) |
Oct 14, 2026 12d ago | SC 13D | $12.21 $15.50 | ▲ +26.95% | ▲ +27.96% | $15.25 (+24.90%) |
Oct 13, 2026 13d ago | Insider Cluster | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $15.25 (+31.01%) |
Oct 13, 2026 13d ago | 3 | $11.64 $15.00 | ▲ +28.87% | ▲ +28.41% | $15.25 (+31.01%) |
Oct 9, 2026 17d ago | 424B4 | $11.32 $16.33 | ▲ +44.26% | ▲ +45.75% | $15.25 (+34.72%) |
Oct 9, 2026 17d ago | EFFECT | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $15.25 (+44.82%) |
Oct 8, 2026 18d ago | 3 | $10.53 $14.07 | ▲ +33.62% | ▲ +35.59% | $15.25 (+44.82%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers